Biotronics3D Ltd

Biotronics3D Ltd develops a cloud-based imaging platform that enhances diagnostic accuracy and operational efficiency in healthcare through integrated RIS and PACS functionalities. Founded in 2004 and headquartered in London, UK, Biotronics3D Ltd specializes in healthcare technology. The company completed its Series A funding round in December 2008, raising GBP 0. 850 mn from Longbow.

The CEO is Haralambos Hatzakis, also known as Harry Hatzakis, who has a history of leadership in the healthcare technology sector. Biotronics3D specializes in a cloud-based imaging platform that integrates advanced Radiology Information System (RIS) and Picture Archiving and Communication System (PACS) functionalities. The offerings focus on enhancing diagnostic accuracy and operational efficiency for healthcare professionals through a fully managed solution that includes a diagnostic viewer, patient and referrer portals, and specialized AI applications. The platform is utilized by over 70,000 users across more than 400 live sites predominantly in Europe, providing comprehensive support for mobile and static imaging operations.

Biotronics3D generates revenue through a subscription-based model that offers scalable access to its imaging platform and associated services. Clients, including hospitals and imaging centers, enter into agreements for the use of the platform that encompass software subscriptions and additional features, allowing for predictable revenue streams based on recurring transactions. Future growth strategies for Biotronics3D include the development of new products, specifically enhancements to their imaging platform aimed at improving diagnostic capabilities. The company is exploring expansion into new geographic regions beyond Europe, with targeted markets expected to be addressed by late 2023.

The funding raised during the Series A round in December 2008 is intended to support these initiatives, enabling further advancements in their product offerings and market penetration.